Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- SUSPENDED
- Phase
- PHASE1
Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML
- Status
- RECRUITING
- Phase
- PHASE2
Selinexor、Venetoclax and Azactidine in the Treatment of ND AML Patients Who Are Not Eligible for Intense Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Study of Q702 With Azacitidine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML
- Status
- RECRUITING
- Phase
- PHASE2
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
- Status
- RECRUITING
- Phase
- PHASE1
The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
- Status
- RECRUITING
- Phase
- N/A
A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- NA
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- NA
Cladribine Venetoclax in Monocytic AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE2